BioSpace News Archive

Diversicare Healthcare Services, Inc., a premier provider of long-term care services, announced today that Ms. Rebecca Bodie will be joining the Company in March 2020 as Executive Vice President and Chief Operating Officer, taking over the position from former Chief Operating Officer, Ms. Leslie Campbell, who resigned effective March 31, 2020..

Evolution Health Group, a full-service, global healthcare communications agency, is pleased to announce that Michael Stevinson has joined their team as Executive Vice President of their blulava division.

Abbott (NYSE: ABT) announced today that four real-world data abstractsi,ii,iii,iv are being presented during the 13th Advanced Technologies & Treatments for Diabetes (ATTD) in Madrid.

AutocathFFR is the only fully workflow-integrated system that enables cardiologists to take better decisions during the diagnostic procedure by providing them with automated image-based stenosis detection and FFR measurement of each captured stenosis.

FORT MYERS, Fla. , Feb. 20, 2020 /PRNewswire/ -- EmCyte, the world leader in platelet rich plasma and progenitor stem cell biologics, announces the acquisition of all of the assets of Cellmedix Holdings LLC, including the Centrepid Platelet Concentrator system. This acquisition bolsters the intellectual property profile of EmCyte Corporation and expands its product developme

PocketPills, Canada’s first full-service digital pharmacy that delivers medication directly to patients, announces $7.35 million in Series A funding.

Feb. 20, 2020 13:00 UTC NEW YORK--( BUSINESS WIRE )-- IVERIC bio, Inc. (Nasdaq: ISEE) today announced that it will report its fourth quarter and full year 2019 financial and operating results on Thursday, February 27, 2020. Following the announcement, the IVERIC bio management team will host a live conference call and webcast at 8:00 a.m. Eastern Time to discuss the Company’s financial results and provide a general business update. To participate in this conference call, di

Geron Corporation reported that it has granted non-statutory stock options to purchase an aggregate of 100,000 shares of Geron common stock as inducements to two newly-hired employees in connection with commencement of employment with the Company.

Liposomal Cyclosporine A for Inhalation (L‑CsA‑i) is advancing in clinical studies for the treatment for bronchiolitis obliterans syndrome (BOS)

Foreign businesses in China are struggling with how to deal with the repercussions of the coronavirus outbreak.